Why Is Cerebras Systems (CBRS) Stock Down -11.73% Today?
Key Takeaways
- CBRS shares fell 11.73% to $231.33 in Thursday morning trading, down $30.73 from Wednesday's close of $262.06.
- The sell-off followed second-quarter results released after Wednesday's close, with revenue of $180.1 million missing Wall Street's consensus estimate of about $194 million.
- An unexpected 23% year-over-year decline in hardware revenue reignited questions about the company's business-model mix and growth predictability.
- Cloud revenue surged, and management raised full-year guidance, but the positive details were overshadowed by the headline miss.
- The stock had rallied 11.6% into the report, leaving it vulnerable to a sell-the-news reaction and elevated post-earnings volatility.
Opening Summary
Cerebras Systems (CBRS) is an artificial-intelligence infrastructure company known for its wafer-scale engine technology, a chip design that uses an entire silicon wafer to accelerate AI training and inference workloads. The company positions itself as a challenger to GPU-based computing platforms such as Nvidia (NVDA).
On Thursday, the stock was down 11.73%, trading at $231.33 as of mid-morning, after closing at $262.06 in the previous session. The move lower was driven by second-quarter earnings released after Wednesday's close. Headline revenue came in below expectations and hardware sales fell sharply, triggering heavy selling in after-hours and premarket trading before shares pared some of their losses in the regular session.
Earnings Miss and Hardware Weakness
The primary catalyst for the decline was a mixed second-quarter report. Cerebras posted revenue of $180.1 million, up 74% from a year earlier but below the roughly $194 million consensus estimate. The company swung to a GAAP net loss of $450.5 million, driven in part by stock-based compensation costs, and reported a GAAP loss of $2.98 per share.
Investors focused particularly on hardware revenue, which fell 23% year over year to $54.1 million. Management described hardware sales as inherently "lumpy," citing order delivery and revenue-recognition timing, as well as customers that do not yet have sufficient data center space to house new systems. For a company priced for rapid AI-infrastructure growth, that sequential softness in hardware was enough to spark aggressive selling.
Cloud Momentum and Raised Guidance Could Not Offset the Reaction
There were clearly positive elements in the report. Core cloud and other services revenue rose 287% year over year to $127.7 million, reflecting strong demand for fast AI inference services. The company also raised its full-year core revenue outlook to between $880 million and $890 million, up from a prior range of $855 million to $865 million, and guided third-quarter core revenue to between $214 million and $216 million.
However, the market reaction showed that the headline miss and hardware weakness carried more weight than the improved guidance. The stock had already surged in recent sessions and entered the print with elevated expectations, which made the room for error extremely thin.
Market Context and Trading Activity
The move in CBRS appeared to be company-specific rather than a broad AI-sector sell-off. Trading activity was heavy as investors repriced the stock following the earnings release, with shares down sharply in after-hours and premarket trading before stabilizing around the $230 level in early regular trading.
The decline erased a large portion of the stock's prior-session gain. After rallying 11.6% into the report, shares pulled back toward levels last seen before the pre-earnings run, testing the $230 area that had acted as a reference point earlier in the month.
What Comes Next for CBRS
Looking ahead, traders will watch whether the company can demonstrate more consistent hardware execution while sustaining its cloud growth. Key areas of focus include hardware order timing, data center capacity expansion, gross-margin trajectory, and progress with large customers and partners.
Management has signaled confidence in the demand environment, pointing to a large backlog and rapid growth in AI inference workloads. Still, risks remain, including hardware revenue lumpiness, stock-based compensation pressure, valuation sensitivity, and post-IPO share volatility. The company's ability to convert its expanding pipeline into smoother reported revenue will likely determine whether the stock can regain its momentum.
Trending AI Robots
For traders looking to systematically monitor moves like this, Tickeron's Trending AI Robots page curates AI trading bots that are performing best under current market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers are featured in this curated section. Bots vary by strategy, timeframe, performance metrics, and traded symbols, giving market participants a focused starting point for further research.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
Momentum Indicator for CBRS turns negative, indicating new downward trend
CBRS saw its Momentum Indicator move below the 0 level on September 30, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 8 similar instances where the indicator turned negative. In 8 of the 8 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for CBRS turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 1 similar instances when the indicator turned negative. In 1 of the 1 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
CBRS moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CBRS entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
CBRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 70 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. CBRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.105) is normal, around the industry mean (7.975). CBRS has a moderately high P/E Ratio (470.757) as compared to the industry average of (165.532). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.761). Dividend Yield (0.000) settles around the average of (0.007) among similar stocks. P/S Ratio (63.694) is also within normal values, averaging (45.794).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
What if the Matching Contribution for My 401(k) is in Company Stock?
If I Want to Establish a SIMPLE IRA, Do I Have to Establish One for All Employees of My Business?
What Is the Compound Annual Growth Rate (CAGR)?
Tickeron Revolutionizes Stocks Trading with AI-Powered Bots
Navigating the Future of Generic Drugs: Top Companies and Emerging Trends
General Information
Industry Semiconductors
Advertisement